Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma

Abstract

Allelic imbalance (AI) studies on chromosome 17 (C17) in Barrett's oesophageal adenocarcinoma (BOA) tumours strongly suggest that a minimally deleted region on C17p harbours a BOA-associated gene with tumour suppressor function. This deleted region, designated minimal region III (MRIII), lies between the two microsatellite markers D17S1852 and D17S954. Computational sequence analysis techniques, BLAST and NIX, were used to assemble a physical map of MRIII, consisting of three overlapping bacterial artificial chromosome (BAC) clones, 297N7, 963H4 and 795F17, from the RPCI-11 library. The 270 kb genomic sequence of MRIII was analysed using the computational gene prediction methods NIX and TAP to identify putative BOA genes. A transcript map of MRIII has been generated and contains 25 candidate BOA genes, four of which are the named genes MYH3, SCO1, x006 and MAGOH-LIKE. The other candidates consist of seven genes predicted by TAP with associated ESTs identified by NIX, two genes predicted by TAP alone and 12 genes/ESTs (or pairs of ESTs) identified by NIX alone. No disease-specific mutations were identified in x006 or MAGOH-LIKE, although expression analysis of these genes suggests that they may show alternative splicing or be altered epigenetically or in regulatory regions in oesophageal cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bruening W, Prowse AH, Schultz DC, Holgado Madruga M, Wong A and Godwin AK . (1999). Cancer Res., 59, 4973–4983.

  • Dolan K, Garde J, Gosney JR, Sissons M, Wright T, Kingsnorth AN, Walker SJ, Sutton R, Meltzer SJ and Field JK . (1998). Br. J. Cancer, 78, 950–957.

  • Dunn J, Garde J, Dolan K, Gosney JR, Sutton R, Meltzer SJ and Field JK . (1999). Oncogene, 18, 987–993.

  • Dunn JR, Garde J, Dolan K, Gosney JR, Oates BC, Watson AJM, Fielding P and Field JK . (2000). Clin. Cancer Res., 6, 4033–4042.

  • Gish W . (1996–2000). WU-BLASTN2. http://blast.wustl.edu/.

  • Harada H, Nagai H, Tsuneizumi M, Mikami I, Sugano S and Emi M . (2001). J. Hum. Genet., 46, 90–95.

  • Hillier LD, Lennon G, Becker M, Bonaldo MF, Chiapelli B, Chissoe S, Dietrich N, DuBuque T, Favello A, Gish W, Hawkins M, Hultman M, Kucaba T, Lacy M, Le M, Le N, Mardis E, Moore B, Morris M, Parsons J, Prange C, Rifkin L, Rohlfing T, Schellenberg K and Marra M . (1996). Genome Res., 6, 807–828.

  • Holscher AH, Bollschweiler E, Schneider PM and Siewert JR . (1997). Br. J. Surg., 84, 1470–1473.

  • Huang J, Hu N, Goldstein AM, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang QH, Dawsey SM, Han XY, Ding T, Li G, Giffen C and Taylor PR . (2000). Carcinogenesis, 21, 2019–2026.

  • Kan Z, Rouchka E, Gish W and States D . (2001). Genome Res, 11, 875–888.

  • Marchese A, Sawzdargo M, Nguyen T, Cheng R, Heng HH, Nowak T, Im DS, Lynch KR, George SR and O'Dowd BF . (1999). Genomics, 56, 12–21.

  • Monaco C, Negrini M, Sozzi G, Veronese ML, Vorechovsky I, Godwin AK and Croce CM . (1997). Genomics, 46, 217–222.

  • Nishiwaki T, Daigo Y, Kawasoe T and Nakamura Y . (2000). Gene Chromosome Cancer, 27, 169–176.

  • Osoegawa K, Mammoser AG, Wu C, Frengen E, Zeng C, Catanese JJ and de Jong PJ . (2001). Genome Res., 11, 483–496.

  • Phillips NJ, Ziegler MR, Radford DM, Fair KL, Steinbrueck T, Xynos FP and Donis-Keller H . (1996). Cancer Res., 56, 606–611.

  • Rankin SC . (2000). Oesophageal Cancer: staging. Practical Management of Oesophage Disease. Adam A, Mason R and Owen WJ (eds) Oxford: Isis Medical Media.

  • Risk JM, Whittaker A, Fryer A, Ellis A, Shaw JM, Field EA, Friedmann PS, Bishop DT, Bodmer J, Leigh IM and Field JK . (1994). Nat. Genet., 8, 319–321.

  • Russell SE, McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Petty EM, Kalikin LM, Church SW, McIlroy S, Harkin DP, Keilty GW, Cranston AN, Weissenbach J, Hickey I and Johnston PG . (2000). Cancer Res., 60, 4729–4734.

  • Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ and Godwin AK . (1996). Cancer Res., 56, 1997–2002.

  • Soenen V, Preudhomme C, Roumier C, Daudignon A, Lai JL and Fenaux P . (1998). Blood, 91, 1008–1015.

  • Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffar S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroede M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J and Cannon-Albright LA . (2001). Nat. Genet., 27, 172–180.

  • Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ and Baylin SB . (1995). Nat. Med., 1, 570–577.

  • Williams GW . (1998). URL: http://www.hgmp.mrc.ac.uk/NIX/.

  • Wittenberger T and Chica Schaller H . (2001). J. Mol. Biol., 307, 799–813.

  • Yamato T, Orikasa K, Fukushige S, Orikasa S and Horii A . (1999). Cytogenet. Cell Genet., 87, 291–295.

  • Zhao XF, Colaizzo-Anas T, Nowak NJ, Shows TB, Elliott RW and Aplan PD . (1998). Genomics, 47, 319–322.

Download references

Acknowledgements

We thank Dr Lakis Liloglou for advice on SSCP analysis. This study was supported by a grant from the North West Cancer Research Fund UK (Grant CR536).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John K Field.

Additional information

Current address: Roy Castle International Centre for Lung Cancer Research

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunn, J., Risk, J., Langan, J. et al. Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma. Oncogene 22, 4134–4142 (2003). https://doi.org/10.1038/sj.onc.1206466

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206466

Keywords

This article is cited by

Search

Quick links